T-cell receptor-derived peptides in immunoregulation and therapy of retrovirally induced immunosuppression

Critical Reviews in Immunology

Volumn 21, Issue 1-3, 2001, Pages 57-74

  Marchalonis, John J ^a   Robey, Ian F ^a   Edmundson, Allen B ^b   Sepulveda, R Tomas ^a   Watson, Ronald R ^c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Aging; AIDS; Cytokines; Monoclonal antibodies; Peptide therapy; TH1; TH2

Indexed keywords

AUTOANTIBODY; CELL SURFACE RECEPTOR; CONCANAVALIN A; IMMUNOGLOBULIN M ANTIBODY; PEPTIDE DERIVATIVE; RECOMBINANT RECEPTOR; T LYMPHOCYTE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; CONFERENCE PAPER; CONTROLLED STUDY; CRYPTOSPORIDIUM; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION RESISTANCE; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; CYTOKINES; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MICE; MOLECULAR SEQUENCE DATA; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RETROVIRIDAE INFECTIONS; T-LYMPHOCYTES;

EID: 0034793726     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (69)

1. Synthetic autoantibodies of immunoglobulins and T-cell receptors: Their recognition in aging, infection and autoimmunity
2. Autoantibodies to the alpha/beta T-cell receptors in human immunodeficiency virus (HIV) infection: Dysregulation and mimicry
3. Analysis of autoantibodies to T-cell receptors among HIV-infected individuals: Epitope analysis and time course
4. Autoantibodies to T-cell receptors following infection by murine retrovirus
5. Production of IgG autoantibodies to T-cell receptors in mice infected with the retrovirus LP-BM5
6. Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain
7. Human autoantibodies to a synthetic putative T cell receptor beta-chain regulatory idiotype: Expression in autoimmunity and aging
8. Natural human antibodies to synthetic peptide autoantigens: Correlations with age and autoimmune disease
9. Evolutionary factors in the emergence of the combinatorial germline antibody repertoire
10. Striking sequence similarity over almost 100 kilobases of human and mouse T cell receptor DNA
11. T cell receptor Vβ CDR1 peptide administration moderates immune dysfunction and cytokine dysregulation induced by murine retrovirus infection
12. Recognition of defined epitopes by affinity purified anti-immunoglobulin Fab autoantibodies isolated from HIV infected humans
13. Autoimmune recognition of acetylocholine receptor and manipulation of the autoimmune responses by synthetic peptides
14. Binding of human IgG myeloma proteins to autologous T-cell receptor determinants
15. Murine AIDS, a key to understand retrovirus-induced immunodeficiency
16. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS
17. + subset regulation in viral infection: Preferential activation of TH2 cells during progression of retrovirus induced immunodeficiency in mice
18. The kinetics of cytokine secretion and proliferation by mesenteric lymph node cells during the progression to murine AIDS, caused by LP-BM5 murine leukemia virus infection
19. Retrovirally induced mouse anti-TCR monoclonals can synergize the in vitro proliferative T cell response to bacterial superantigens
20. The T-cell receptor as immunoglobulin: Paradigm regained
21. Effects of vaccination against different T cell receptors on maintenance of immune function during murine retrovirus infection
22. Effects of T cell receptor dose and term of application during murine retrovirus infection and maintenance of immune function
23. Prevention of immune dysfunction vitamin E deficiency and loss of Cryptosporidium resistance during murine retrovirus infection by T-cell receptor peptide immunization
24. Prevention of retro-virus induced aberrant cytokine secretion, excessive lipid peroxidation, and tissue vitamin E deficiency by T cell receptor peptide treatments in C57BL/6 mice
25. Injection of T-cell receptor peptide reduces immunosenescence in aged C57BL/6 mice
26. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus
27. Antioxidant supplementation in prevention and treatment of immune dysfunction and oxidation induced by murine AIDS in old mice
28. Reactions of anti-immunoglobulin sera with synthetic T cell receptor peptides: Implications for the three-dimensional structure and function of the TCR beta chain
29. Definition of a physiologic aging autoantigen by using synthetic peptides of membrane protein band 3: Localization of the active antigenic sites
30. Murine AIDs superantigen reactivity of the T cells bearing Vbeta5 T cell antigen receptor
31. Conservation of immunoglobulin variable and joining region structure and the design of universal anti-immunoglobulin antibodies reactive with antigen-binding T cell receptors
32. Immunoglobulin epitopes defined by synthetic peptides corresponding to joining region sequence: Conservation of determinants and dependence upon the presence of an arginyl or lysyl residue for cross-reaction between light chains and T-cell receptor chains
33. Antibodies to synthetic joining segment peptide of the T-cell receptor beta-chain: Serological cross-reaction between products of T-cell receptor genes, antigen binding T-cell receptors, and immunoglobulins
34. Conservation among vertebrate immunoglobulin chains detected by antibodies to a synthetic joining segment peptide
35. Molecular mimicry and immune-mediated diseases
36. Autoreactivity in HIV-1 infection: The role of molecular mimicry
37. Molecular mimicry between HIV and antigen-receptor molecules: A clue to the pathogenesis of AIDS
38. Aging and the immune response
39. Relationship between aging and the immune system
40. Evidence of enhanced type 2 immune response and impaired upregulation of a type 1 response in frail elderly nurasing home residents
41. Epitope promiscuity of human monoclonal autoantibodies to T cell receptor combining site determinants
42. Production and characterization of monoclonal IgM autoantibodies specific for the T cell receptor
43. Immunoregulating properties of peptides related to tumor rejection antigens: Effect on human monocytes and natural killer cells
44. Activation of human T helper 1 and DNase expression in CD4-induced by short immunomodulating peptides
45. Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha and bacteria induced IL-8 and IL1 beta secretion from intestinal epithelial cells
46. Granuloma T lymphocytes in murine schistomsomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFN-gamma secretion
47. Cell-specific peptide binding by human neutrophils
48. Somatostatin analogues suppress the inflammatory reaction in vivo
49. T cell receptor peptide vaccination in rheumatoid arthritis
50. Targeting the T cell receptor in rheumatoid arthritis
51. Treatment of multiple sclerosis with T-cell receptor peptides: Results of a double-blind pilot trial
52. Cross-reactivity of MBP-specific T cells with multiple microbial peptides: EAE induction in transgenic mice
53. Multiple cross reactive self-ligands for Borrelia burgdorferi specific HLA-DR4-restricted T cells
54. T cell tolerance is influenced by concomitant T cell recognition of cross-reactive self-peptides
55. Short peptide based tolerongens without self-antigenic or pathogenic activity reverse autoimmune disease
56. T lymphocytes infiltrating sites of tumor rejection and progression display identical Vbeta usage but [difference] cytotoxic activities
57. Substance P and somatostatin can modulate the amount of IgG2a secreted in response to schistosome egg antigens in murine schistosomiasis mansoni
58. Modulation of cytokine production in activated human monocytes by somatostatin
59. Substance P regulates somatostatin expression in inflammation
60. Immunomodulatory effects of peptide T on Th1/Th2 cytokines
61. Redirecting Th2 responses in allergy
62. Th1/Th2 balance in infection
63. An altered peptide ligand specifically inhibits Th2 cytokine synthesis by abrogating TCR signaling
64. Developmental commitment to the TH2 lineage by extinction of IL-12 signalling
65. Nature of variation among variable genes
66. Crystal structure of the β chain of a T-cell antigen receptor
67. Rotational allomerision and divergent evolution of domains in immunoglobulin light chains
68. MOLMOL: A program for display and analysis of macromolecular structures